These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32383026)

  • 21. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
    Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroinflammation and psychiatric disorders: Relevance of C1q, translocator protein (18 kDa) (TSPO), and neurosteroids.
    Rupprecht R; Rupprecht C; Di Benedetto B; Rammes G
    World J Biol Psychiatry; 2022; 23(4):257-263. PubMed ID: 34320915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
    Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders?
    Rupprecht R; Wetzel CH; Dorostkar M; Herms J; Albert NL; Schwarzbach J; Schumacher M; Neumann ID
    Mol Psychiatry; 2022 Jul; 27(7):2918-2926. PubMed ID: 35444254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocator protein ligands as promising therapeutic tools for anxiety disorders.
    Taliani S; Da Settimo F; Da Pozzo E; Chelli B; Martini C
    Curr Med Chem; 2009; 16(26):3359-80. PubMed ID: 19548867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anxiolytic effect of koumine on a predatory sound stress-induced anxiety model and its associated molecular mechanisms.
    Xiong B; Zhong Z; Chen C; Huang H; Lin J; Xu Y; Yang J; Yu C
    Phytomedicine; 2022 Aug; 103():154225. PubMed ID: 35689899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.
    Nothdurfter C; Baghai TC; Schüle C; Rupprecht R
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S107-12. PubMed ID: 22923187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.
    Nothdurfter C; Rammes G; Baghai TC; Schüle C; Schumacher M; Papadopoulos V; Rupprecht R
    J Neuroendocrinol; 2012 Jan; 24(1):82-92. PubMed ID: 21609361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of the 18-kDa translocator protein (TSPO) ligand etifoxine on steroidogenesis in rat brain, plasma and steroidogenic glands: Pharmacodynamic studies.
    Liere P; Pianos A; Oudinet JP; Schumacher M; Akwa Y
    Psychoneuroendocrinology; 2017 Sep; 83():122-134. PubMed ID: 28609670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midazolam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodiazepine receptor activation and neurosteroidogenesis.
    Tokuda K; O'Dell KA; Izumi Y; Zorumski CF
    J Neurosci; 2010 Dec; 30(50):16788-95. PubMed ID: 21159950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparable Intestinal and Hepatic First-Pass Effect of YL-IPA08 on the Bioavailability and Effective Brain Exposure, a Rapid Anti-PTSD and Anti-Depression Compound.
    Gao Y; Yang C; Wang L; Xiang Y; Zhang W; Li Y; Zhuang X
    Front Pharmacol; 2020; 11():588127. PubMed ID: 33328995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model.
    Ishikawa M; Yoshitomi T; Covey DF; Zorumski CF; Izumi Y
    Neuropharmacology; 2016 Dec; 111():142-159. PubMed ID: 27596950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of allopregnanolone in the anti-PTSD-like effects of AC-5216.
    Zhang LM; Qiu ZK; Chen XF; Zhao N; Chen HX; Xue R; Zhang YZ; Yang RF; Li YF
    J Psychopharmacol; 2016 May; 30(5):474-81. PubMed ID: 26783231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations.
    Bruno A; Barresi E; Simola N; Da Pozzo E; Costa B; Novellino E; Da Settimo F; Martini C; Taliani S; Cosconati S
    ACS Chem Neurosci; 2019 Aug; 10(8):3805-3814. PubMed ID: 31268683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy.
    Giatti S; Pesaresi M; Cavaletti G; Bianchi R; Carozzi V; Lombardi R; Maschi O; Lauria G; Garcia-Segura LM; Caruso D; Melcangi RC
    Neuroscience; 2009 Dec; 164(2):520-9. PubMed ID: 19665520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injection of oxytocin into paraventricular nucleus reverses depressive-like behaviors in the postpartum depression rat model.
    Wang T; Shi C; Li X; Zhang P; Liu B; Wang H; Wang Y; Yang Y; Wu Y; Li H; Xu ZD
    Behav Brain Res; 2018 Jan; 336():236-243. PubMed ID: 28889022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antidepressant and anxiolytic effect of GPER on translocator protein (TSPO) via protein kinase a (PKA) signaling in menopausal female rats.
    Wang J; Li HY; Shen SY; Zhang JR; Liang LF; Huang HJ; Li B; Wu GC; Zhang YQ; Yu J
    J Steroid Biochem Mol Biol; 2021 Mar; 207():105807. PubMed ID: 33345973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options.
    Rupprecht R; Pradhan AK; Kufner M; Brunner LM; Nothdurfter C; Wein S; Schwarzbach J; Puig X; Rupprecht C; Rammes G
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1477-1487. PubMed ID: 36574032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The non-benzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis.
    do Rego JL; Vaudry D; Vaudry H
    PLoS One; 2015; 10(3):e0120473. PubMed ID: 25785994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of Anxiety and Depression by Mitochondrial Translocator Protein-Mediated Steroidogenesis: the Role of Neurons.
    Barron AM; Higuchi M; Hattori S; Kito S; Suhara T; Ji B
    Mol Neurobiol; 2021 Feb; 58(2):550-563. PubMed ID: 32989676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.